Management of Elevated C3 Complement Levels

Clinical Significance and Evaluation

Infections, such as bacterial, viral, or fungal infections, should be considered as common causes of systemic inflammation in patients with elevated C3 levels, according to Praxis Medical Insights 1
Autoimmune disorders should also be evaluated as potential causes of systemic inflammation in patients with elevated C3 levels, as recommended by Praxis Medical Insights 1

A complete urinalysis with sediment evaluation should be considered if elevated C3 is accompanied by clinical signs of glomerular disease, as suggested by Praxis Medical Insights 2
24-hour urine protein quantification, significant if greater than 500 mg/day, should be performed to assess proteinuria in patients with elevated C3 and suspected glomerular disease, according to Praxis Medical Insights 2
Renal function tests, including creatinine and BUN, should be evaluated in patients with suspected renal involvement and elevated C3, as recommended by Praxis Medical Insights 2

A kidney biopsy may be indicated to determine the specific glomerular pathology in patients with suspected renal involvement and elevated C3, as suggested by Kidney International and Praxis Medical Insights 2, 3

Low C3 with normal C4 suggests alternative pathway activation, as seen in C3 glomerulopathy, according to Praxis Medical Insights 2, 4
Low C3 and low C4 suggest classical pathway activation, as seen in immune complex-mediated diseases, as recommended by Praxis Medical Insights 1, 2
The IgG + C3 immunofluorescence pattern on kidney biopsy indicates immune complex-mediated glomerulonephritis, which is different from isolated elevated serum C3, according to Praxis Medical Insights 1

For immune complex-mediated MPGN with nephrotic syndrome and declining kidney function, the American Journal of Kidney Diseases recommends considering oral cyclophosphamide or mycophenolate mofetil plus low-dose corticosteroids (therapy limited to less than 6 months) 5